IGM Biosciences (IGMS)
(Delayed Data from NSDQ)
$6.97 USD
-0.23 (-3.19%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $6.75 -0.22 (-3.16%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/10/24 |
---|---|
Current Quarter | -0.84 |
EPS Last Quarter | -1.01 |
Last EPS Surprise | 4.72% |
ABR | 2.00 |
Earnings ESP
|
1.69% |
---|---|
Current Year | -3.23 |
Next Year | -3.03 |
EPS (TTM) | -4.81 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.71M | 0.74M | 3.07M | 27.08M |
# of Estimates | 6 | 6 | 5 | 3 |
High Estimate | 0.75M | 0.75M | 3.43M | 48.75M |
Low Estimate | 0.58M | 0.70M | 2.90M | 15.00M |
Year ago Sales | 0.52M | 0.45M | 2.13M | 3.07M |
Year over Year Growth Est. | 37.12% | 64.00% | 43.94% | 783.33% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.84 | -0.81 | -3.23 | -3.03 |
# of Estimates | 7 | 6 | 6 | 6 |
Most Recent Consensus | -0.81 | -0.79 | -3.27 | -3.07 |
High Estimate | -0.81 | -0.76 | -3.08 | -2.04 |
Low Estimate | -0.93 | -0.84 | -3.39 | -3.54 |
Year ago EPS | -1.33 | -1.43 | -4.71 | -3.23 |
Year over Year Growth Est. | 36.84% | 43.36% | 31.42% | 6.35% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 3 | 3 | 5 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.84 | -0.81 | -3.23 | -3.03 |
7 Days Ago | -0.84 | -0.81 | -3.23 | -3.03 |
30 Days Ago | -0.85 | -0.81 | -3.37 | -2.98 |
60 Days Ago | -0.93 | -0.90 | -3.72 | -3.56 |
90 Days Ago | -0.93 | -0.90 | -3.84 | -3.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.83 | -0.81 | -3.21 | -3.25 |
Zacks Consensus Estimate | -0.84 | -0.81 | -3.23 | -3.03 |
Earnings ESP | 1.69% | 0.00% | 0.72% | -7.32% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.01 | -1.04 | -1.43 | -1.33 | NA |
Estimate | -1.06 | -1.25 | -1.43 | -1.37 | NA |
Difference | 0.05 | 0.21 | 0.00 | 0.04 | 0.08 |
Surprise | 4.72% | 16.80% | 0.00% | 2.92% | 6.11% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more